|
2024
|
P/S
|
Cell preparations for medical use in cell therapy for the treatment and prevention of oncologic d... |
|
|
Invention
|
Nant covid vaccine cross reactivity.
Recombinant SARS-CoV2 vaccine compositions and methods are ... |
|
|
Invention
|
Tumoricidal and antimicrobial compositions and methods.
Provided herein are pharmaceutical compo... |
|
|
Invention
|
Chimeric antigen receptor-modified nk-92 cells.
Provided are NK-92 cells expressing a chimeric a... |
|
|
Invention
|
Advanced avatar dendritic cells.
Compositions, methods, and uses of recombinant immunoglobulin p... |
|
|
Invention
|
Biological deposit labeling and tracking.
Methods and systems are provided herein to track an or... |
|
|
Invention
|
Single-chain chimeric polypeptides and uses thereof.
Provided herein are single-chain chimeric p... |
|
|
P/S
|
Printed publications providing information on diagnosis and prognosis of disease Providing inform... |
|
|
Invention
|
Adenoviral vector transduced apheresis product.
An immunotherapeutic composition is contemplated... |
|
|
Invention
|
Adenoviral vector transduced apheresis product. ex-vivoex-vivo to the at least one Ad5 vector. Ad... |
|
|
P/S
|
Pharmaceutical preparations and substances for the treatment of human diseases and animal disease... |
|
|
Invention
|
Nant covid vaccine cross reactivity. Recombinant SARS-CoV2 vaccine compositions and methods are p... |
|
|
Invention
|
Cell-mediated transient delivery of immune-enhancing molecules into the tumor microenvironment.
... |
|
|
P/S
|
Pharmaceutical preparations and substances for the treatment of immunologic dysfunction, cancer, ... |
|
|
Invention
|
Il-12/il-18 superkines.
Provided herein are novel soluble-fusion protein complexes comprising in... |
|
|
Invention
|
Il-12/il-18 superkines. Provided herein are novel soluble fusion protein complexes comprising int... |
|
|
Invention
|
Method and system for t-cell receptor (tcr) assay design.
A system and method of designing a T-c... |
|
|
Invention
|
Method and system for t-cell receptor (tcr) assay design. A system and method of designing a T-ce... |
|
|
Invention
|
Generating cik nkt cells from cord blood.
Provided herein are methods and customized media compo... |
|
2023
|
Invention
|
Content authentication and validation via multi-factor digital tokens, systems, and methods.
Aut... |
|
|
Invention
|
Fiducial localization with sparse annotations. A system and method are described. An illustrative... |
|
|
Invention
|
Compositions and methods of mait cell activation.
B cell proliferation and/or memory B cell form... |
|
|
Invention
|
Compositions and methods of mait cell activation. in vivoin vivo immune stimulation will be perfo... |
|
|
Invention
|
Multi-chain chimeric polypeptides and uses thereof.
Provided herein are multi-chain chimeric pol... |
|
|
Invention
|
Anti covid-19 therapies targeting nucleocapsid and spike proteins.
Disclosed herein are methods ... |
|
|
Invention
|
Nant cancer vaccine strategies.
A patient having cancer can be treated using coordinated treatme... |
|
|
P/S
|
Pharmaceutical preparations and substances for the treatment of human and animal diseases, includ... |
|
|
P/S
|
Pharmaceutical preparations and substances for the treatment
of human and animal diseases, inclu... |
|
|
Invention
|
Use of cd33car modified high affinity nk cells (t-hank) to reduce myeloid-derived suppressor cell... |
|
|
Invention
|
Modified nk-92 cells for treating cancer.
Provided herein are NK-92 cells expressing at least on... |
|
|
Invention
|
Treatment of mhc-i negative tumors with nk and t cells. Methods and compositions are provided her... |
|
|
Invention
|
Computing affinity for protein-protein interaction.
Techniques are provided for computing affini... |
|
|
P/S
|
Pharmaceutical preparations and substances for the treatment of human diseases, animal diseases, ... |
|
|
P/S
|
Pharmaceutical preparations and substances for the treatment
of human diseases, animal diseases,... |
|
|
Invention
|
Multi-chain chimeric polypeptides and uses thereof.
The present disclosure relates to methods th... |
|
|
Invention
|
Modified nk-92 hank003 cells for the clinic.
Provided herein are populations of modified NK-92 c... |
|
|
Invention
|
Methods for stimulating proliferation or differentiation of an immune cell with a multi-chain chi... |
|
|
Invention
|
Cd16high cd57high nk-92mi cells.
Cells and cell-based therapeutic compositions and methods are p... |
|
|
Invention
|
Cd16high cd57high nk-92mi cells. Cells and cell-based therapeutic compositions and methods are pr... |
|
|
Invention
|
Methods of treating aging-related disorders.
Provided herein are methods of treating an aging-re... |
|
|
Invention
|
Methods of reducing neuroinflammation.
Provided herein are multi-chain chimeric polypeptides and... |
|
|
Invention
|
Intratumorally injected yeast vaccine.
Disclosed herein are compositions and methods for treatin... |
|
|
Invention
|
Intratumorally injected yeast vaccine. The present invention relates to a composition for injecti... |
|
|
Invention
|
Fc-epsilon car.
Recombinant NK cells, and especially recombinant NK-92 cells express a chimeric ... |
|
2022
|
Invention
|
Fiducial localization with sparse annotations.
A system and method are described. An illustrativ... |
|
|
P/S
|
Medicinal preparations; biological preparations; pharmaceutical preparations; vaccines; all of th... |
|
|
P/S
|
Medicinal preparations; biological preparations;
pharmaceutical preparations; vaccines; all of t... |
|
|
Invention
|
Neoepitope vaccine delivery vehicle and methods of making the same. Disclosed herein are mannan n... |
|
|
Invention
|
Natural killer cells for chordoma therapy.
Provided herein are methods and compositions for trea... |
|
|
Invention
|
Enzyme based system for production of messenger rna with increased transfection efficiency.
A me... |
|
|
Invention
|
Chimeric antigen receptor-modified nk-92 cells. Provided are NK-92 cells expressing a chimeric an... |
|
|
P/S
|
Pharmaceutical preparations for the prevention and treatment of cancer, namely, pharmaceutical pr... |
|
|
P/S
|
Cells; cell-derived preparations; medicinal, biological and pharmaceutical preparations; products... |
|
|
Invention
|
Highly potent m-cenk cells and methods.
Memory-like cytokine enhanced NK (M-CENK) cells have sup... |
|
2021
|
Invention
|
Fc-receptor car constructs and cells.
Chimeric antigen receptors with an antibody-binding domain... |
|
|
P/S
|
Medicinal preparations, biological preparations, pharmaceutical preparations, human vaccines, imm... |
|
|
P/S
|
Medicinal preparations; biological preparations for medical and pharmaceutical purposes; pharmace... |
|
|
P/S
|
Medicinal preparations; biological preparations; pharmaceutical preparations; vaccines; immune bo... |
|
|
P/S
|
Medicinal preparations; biological preparations for medical
and pharmaceutical purposes; pharmac... |
|
|
P/S
|
Medicinal preparations, biological preparations, pharmaceutical preparations, human vaccines, im... |
|
|
P/S
|
Medicinal preparations; biological preparations;
pharmaceutical preparations; vaccines; immune b... |
|
|
P/S
|
Research in the field of cancer and infectious diseases;
product development in the fields of sc... |
|
|
Invention
|
Method of inducing immunity against sars-cov-2 using spike (s) and nucleocapsid (n)-etsd immunoge... |
|
2020
|
Invention
|
Detecting homologous recombination deficiencies (hrd) in clinical samples.
Disclosed herein are ... |
